This novel ALL subtype, called Ph-like or BCR–ABL1-like ALL, was characterized by a high frequency of deletions in genes involved in B-cell development (e.g., IKZF1) and by an unfavorable prognosis, with disease free survival rates comparable to that of pediatric patients with the Ph-positive ALL [27]. Here, ABL1 is linked to acute lymphoblastic leukemia.